Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.
Medve
László
L
Department of Anesthesiology, Szent Lázár County Hospital, Salgótarján, Hungary. medve561@axelero.hu
Csitári
István Kis
IK
Molnár
Zsolt
Z
László
Adám
A
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011262:Pregnancy Trimester, Second; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy* / Q000209:etiology; D014552:Urinary Tract Infections / Q000150:complications
D005343:Fibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins